NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

31 hedge funds and large institutions have $3.13M invested in Navidea Biopharmaceuticals Inc. in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$385K
Puts
$566K
Net Calls
Net Calls Change

Top Sellers

1 -$266K
2 -$183K
3 -$75.6K
4
Squarepoint
Squarepoint
New York
-$58K
5
Group One Trading
Group One Trading
Illinois
-$40.4K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.33M
2
$315K
3
$281K
4
$189K
5
$187K
6
$177K
7
$135K
8
$118K
9
$77K
10
$72K
11
$51K
12
$50K
13
$44K
14
$24K
15
$21K
16
$18K
17
$12K
18
$9K
19
$3K
20
$3K
21
$2K
22
$2K
23
$1K
24
$1K
25
$1K